https://orcid.org/0000-0001-9659-0276
References
- Armstrong DG, Boulton AJM, Bus SA. Diabetic foot ulcers and their recurrence. N Engl J Med. 2017;376:1–7.
- Almaraz MC, González-Romero S, Bravo M, et al. Incidence of lower limb amputations in individuals with and without diabetes mellitus in Andalusia (Spain) from 1998 to 2006. Diabetes Res Clin Pract. 2012;95:399–405.
- Trautner C, Haastert B, Spraul M, et al. Unchanged incidence of lower-limb amputations in a German City, 1990-1998. Diabetes Care. 2001;24:855–859. [cited 2018 Nov 24]. Available from: http://www.ncbi.nlm.nih.gov/pubmed/11347743
- Rice JB, Desai U, Cummings AKG, et al. Burden of diabetic foot ulcers for medicare and private insurers. Diabetes Care. 2014;37:651–658.
- Thorud JC, Plemmons B, Buckley CJ, et al. Mortality after nontraumatic major amputation among patients with diabetes and peripheral vascular disease: a systematic review. J Foot Ankle Surg. 2016;55:591–599.
- Shah SK, Bena JF, Allemang MT, et al. Lower extremity amputations: factors associated with mortality or contralateral amputation. Vasc Endovascular Surg. 2013;47:608–613.
- Hoffstad O, Mitra N, Walsh J, et al. Diabetes, Lower-Extremity amputation, and death. Diabetes Care. 2015;38:1852–1857.
- Faglia E, Clerici G, Caminiti M, et al. Mortality after major amputation in diabetic patients with critical limb ischemia who did and did not undergo previous peripheral revascularization. Data of a cohort study of 564 consecutive diabetic patients. J Diabetes Complications. 2010;24:265–269.
- Monteiro-Soares M, Boyko EJ, Ribeiro J, et al. Predictive factors for diabetic foot ulceration: a systematic review. Diabetes Metab Res Rev. 2012;28:574–600.
- Faglia E. Characteristics of peripheral arterial disease and its relevance to the diabetic population. Int J Low Extrem Wounds. 2011;10:152–166.
- Faglia E, Dalla Paola L, Clerici G, et al. Peripheral angioplasty as the first-choice revascularization procedure in diabetic patients with critical limb ischemia: prospective study of 993 consecutive patients hospitalized and followed between 1999 and 2003. Eur J Vasc Endovasc Surg. 2005;29:620–627.
- Rümenapf G, Morbach S. What can i do with a patient with diabetes and critically impaired limb perfusion who cannot be revascularized? Int J Low Extrem Wounds. 2014;13:378–389.
- Benoit E, O’Donnell TF, Kitsios GD, et al. Improved amputation-free survival in unreconstructable critical limb ischemia and its implications for clinical trial design and quality measurement. J Vasc Surg. 2012;55:781–789.
- American Diabetes Association AD. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2014;37(Suppl 1): S81–90.
- Norgren L, Hiatt WR, Dormandy JA, et al. Inter-society consensus for the management of peripheral arterial disease (TASC II). J Vasc Surg. 2007;45:S5–S67.
- Klomp HM, Spincemaille GH, Steyerberg EW, et al. Spinal-cord stimulation in critical limb ischaemia: a randomised trial. ESES Study Group. Lancet. 1999;353:1040–1044. [cited 2018 Nov 28]. Available from: http://www.ncbi.nlm.nih.gov/pubmed/10199350
- Amann W, Berg P, Gersbach P, et al. European peripheral vascular disease outcome study SCS-EPOS. Spinal cord stimulation in the treatment of non-reconstructable stable critical leg ischaemia: results of the European peripheral vascular disease outcome study (SCS-EPOS). Eur J Vasc Endovasc Surg. 2003;26:280–286. [cited 2018 Nov 28]. Available from: http://www.ncbi.nlm.nih.gov/pubmed/14509891
- Nikol S, Baumgartner I, Van Belle E, et al. Therapeutic angiogenesis with intramuscular NV1FGF improves amputation-free survival in patients with critical limb ischemia. Mol Ther. 2008;16:972–978.
- Marston WA, Davies SW, Armstrong B, et al. Natural history of limbs with arterial insufficiency and chronic ulceration treated without revascularization. J Vasc Surg. 2006;44:108–114.e1.
- Baer-Bositis HE, Hicks TD, Haidar GM, et al. Outcomes of reintervention for recurrent symptomatic disease after tibial endovascular intervention. J Vasc Surg. 2018;68:811–821.e1.